CHICAGO--(BUSINESS WIRE)--We are delighted to announce that Howard Schwartz, MD has joined Monarch Specialty Group as a Practice Associate.
Monarch Specialty Group’s clients are pharmaceutical manufacturers and pharmacy practices facing complex market access challenges involving specialty biologics requiring sophisticated and experienced commercial advisers.
In his role, Dr. Schwartz will assist Monarch Specialty Group’s work with manufacturer and pharmacy clients regarding the company’s provider and patient hub support services as well as supporting new market access strategies for orphan drugs and related specialty biologics.
“Dr. Schwartz brings to the company a unique combination of medical practice and relevant commercial experience relating to specialty biologics that will add depth of knowledge to what is already a best-in-class contract commercial operations team,” said Stephen Cichy, Founder and Managing Director of Monarch Specialty Group.
In addition to medical practice, Dr. Schwartz’s experience includes leading over 1000 clinical trials in multiple therapeutic areas including gastroenterology, oncology, vaccines, women’s health, sleep medicine, weight loss, nutraceuticals, endocrinology, neurology, psychiatry, rheumatology, and pulmonary medicine. Prior to joining Monarch Specialty Group, Dr. Schwartz served as Chief Medical Officer of QPS Holdings, and President of QPS MRA, its subsidiary. QPS is a US-based, international GLP/GCP-compliant contract research organization supporting discovery, preclinical and clinical drug development. Prior to its sale to QPS, Dr. Schwartz was the Chief Executive Officer and Medical Director of Miami Research Associates, Inc., a privately held multi-specialty clinical research organization serving the pharmaceutical industry.
Dr. Schwartz is board certified in gastroenterology & internal medicine and a fellow of the American College of Physicians & American Gastroenterology Association.
For more information about Monarch Specialty Group contact us online at www.monarchsp.com.
About Monarch Specialty Group: Founded in 2012, Monarch Specialty Group is a Chicago-based growth partnership firm and investment company focused on cultivating opportunities on behalf of orphan drugs and related specialty biologics. The company partners with pharmaceutical manufacturers, pharmacy distributors, financial institutions and related stakeholder organizations to assist market access, leverage technology, and stimulate growth. In turning to Monarch Specialty Group, clients tap into the company’s extensive industry relationships and expertise to succeed in an increasingly dynamic health care environment.